Financhill
Back

Blueprint Medicines Vs. Novo Nordisk AS Industry Stock Comparison

Sell
40

BPMC
Blueprint Medicines

Last Price:
$90.24
Seasonality Move:
2.18%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $90.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 540770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.73 - 96.57) Sell
Bollinger Bands (100): (87.46 - 96.54) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.44 Sell
50-day SMA: 92.37 Sell
200-day SMA: 96.72 Sell
8-day EMA: 92.45 Sell
20-day EMA: 93.6 Sell
50-day EMA: 93.36 Sell
200-day EMA: 91.74 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):